• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在一例实性乳头状甲状腺癌中检测到一种新的BRAF基因突变。

A new BRAF gene mutation detected in a case of a solid variant of papillary thyroid carcinoma.

作者信息

Trovisco Vítor, Soares Paula, Soares Ricardo, Magalhães João, Sá-Couto Pedro, Sobrinho-Simões Manuel

机构信息

Institute of Molecular Pathology and Immunology of the University of Porto, Porto, Portugal.

出版信息

Hum Pathol. 2005 Jun;36(6):694-7. doi: 10.1016/j.humpath.2005.04.011.

DOI:10.1016/j.humpath.2005.04.011
PMID:16021577
Abstract

BRAF gene mutations have been frequently detected in papillary thyroid carcinoma (PTC). Moreover, there is a close association between the type of mutation and the PTC histotype: BRAF(V600E) is associated with conventional PTC and with histological variants of PTC displaying a prominent papillary growth pattern, whereas BRAF(K601E) is associated with the follicular variant of PTC. We report the detection of a novel BRAF triplet deletion in a case of PTC displaying a predominantly solid growth pattern. The deletion leads to the replacement of a valine and a lysine by a glutamate in the BRAF activation segment (BRAF(VK600-1E)), thus mimicking partially the 2 BRAF mutations previously described. Our study reinforces the existence of a close relationship between the occurrence of some types of BRAF mutation and some PTC histotypes. The genetic study of more cases of the solid variant of PTC is necessary to find whether there exists a significant association between the occurrence of BRAF(VK600-1E) and such PTC histotype.

摘要

BRAF基因突变在甲状腺乳头状癌(PTC)中经常被检测到。此外,突变类型与PTC组织学类型之间存在密切关联:BRAF(V600E)与传统PTC以及呈现显著乳头状生长模式的PTC组织学变体相关,而BRAF(K601E)与PTC的滤泡变体相关。我们报告了在一例主要呈实性生长模式的PTC病例中检测到一种新的BRAF三联体缺失。该缺失导致BRAF激活区中的缬氨酸和赖氨酸被谷氨酸取代(BRAF(VK600 - 1E)),从而部分模拟了先前描述的两种BRAF突变。我们的研究强化了某些类型的BRAF突变与某些PTC组织学类型之间存在密切关系这一观点。有必要对更多实性变体PTC病例进行遗传学研究,以确定BRAF(VK600 - 1E)的出现与这种PTC组织学类型之间是否存在显著关联。

相似文献

1
A new BRAF gene mutation detected in a case of a solid variant of papillary thyroid carcinoma.在一例实性乳头状甲状腺癌中检测到一种新的BRAF基因突变。
Hum Pathol. 2005 Jun;36(6):694-7. doi: 10.1016/j.humpath.2005.04.011.
2
BRAF mutations are associated with some histological types of papillary thyroid carcinoma.BRAF突变与某些组织学类型的甲状腺乳头状癌相关。
J Pathol. 2004 Feb;202(2):247-51. doi: 10.1002/path.1511.
3
BRAF mutation associated with other genetic events identifies a subset of aggressive papillary thyroid carcinoma.与其他基因事件相关的BRAF突变可识别侵袭性乳头状甲状腺癌的一个亚组。
Clin Endocrinol (Oxf). 2008 Apr;68(4):618-34. doi: 10.1111/j.1365-2265.2007.03077.x. Epub 2007 Dec 5.
4
Genotyping of an Italian papillary thyroid carcinoma cohort revealed high prevalence of BRAF mutations, absence of RAS mutations and allowed the detection of a new mutation of BRAF oncoprotein (BRAF(V599lns)).对一组意大利乳头状甲状腺癌患者进行基因分型发现,BRAF突变的发生率很高,不存在RAS突变,并检测到一种新的BRAF癌蛋白突变(BRAF(V599lns))。
Clin Endocrinol (Oxf). 2006 Jan;64(1):105-9. doi: 10.1111/j.1365-2265.2005.02401.x.
5
Type and prevalence of BRAF mutations are closely associated with papillary thyroid carcinoma histotype and patients' age but not with tumour aggressiveness.BRAF突变的类型和发生率与甲状腺乳头状癌的组织类型及患者年龄密切相关,但与肿瘤侵袭性无关。
Virchows Arch. 2005 Jun;446(6):589-95. doi: 10.1007/s00428-005-1236-0. Epub 2005 May 19.
6
Correlation between B-RAFV600E mutation and clinico-pathologic parameters in papillary thyroid carcinoma: data from a multicentric Italian study and review of the literature.甲状腺乳头状癌中B-RAFV600E突变与临床病理参数的相关性:来自一项意大利多中心研究的数据及文献综述
Endocr Relat Cancer. 2006 Jun;13(2):455-64. doi: 10.1677/erc.1.01086.
7
Evidence that one subset of anaplastic thyroid carcinomas are derived from papillary carcinomas due to BRAF and p53 mutations.有证据表明,一部分间变性甲状腺癌是由于BRAF和p53突变而由乳头状癌演变而来。
Cancer. 2005 Jun 1;103(11):2261-8. doi: 10.1002/cncr.21073.
8
Association of BRAF V600E mutation with poor clinicopathological outcomes in 500 consecutive cases of papillary thyroid carcinoma.500例连续乳头状甲状腺癌患者中BRAF V600E突变与不良临床病理结局的相关性
J Clin Endocrinol Metab. 2007 Nov;92(11):4085-90. doi: 10.1210/jc.2007-1179. Epub 2007 Sep 4.
9
BRAF mutation detection in indeterminate thyroid cytology specimens: underlying cytologic, molecular, and pathologic characteristics of papillary thyroid carcinoma.甲状腺不典型细胞学标本中 BRAF 突变的检测:甲状腺乳头状癌的潜在细胞学、分子和病理学特征。
Cancer Cytopathol. 2013 Apr;121(4):197-205. doi: 10.1002/cncy.21229. Epub 2012 Aug 7.
10
[Expression of BRAF V600E mutation in different thyroid lesions].[BRAF V600E突变在不同甲状腺病变中的表达]
Zhonghua Zhong Liu Za Zhi. 2011 May;33(5):354-7.

引用本文的文献

1
Unveiling a rare BRAF mutation in minimally invasive follicular thyroid carcinoma: A case report.揭示微小浸润滤泡状甲状腺癌中的罕见 BRAF 突变:病例报告。
Medicine (Baltimore). 2024 Aug 23;103(34):e39364. doi: 10.1097/MD.0000000000039364.
2
Aggressive variants of follicular cell-derived thyroid carcinoma: an overview.滤泡细胞来源的甲状腺癌的侵袭性变异型:概述。
Endocrine. 2022 Oct;78(1):1-12. doi: 10.1007/s12020-022-03146-0. Epub 2022 Jul 21.
3
Molecular Pathology of Non-familial Follicular Epithelial-Derived Thyroid Cancer in Adults: From RAS/BRAF-like Tumor Designations to Molecular Risk Stratification.
成人非家族性滤泡上皮来源甲状腺癌的分子病理学:从 RAS/BRAF 样肿瘤分类到分子风险分层。
Endocr Pathol. 2021 Mar;32(1):44-62. doi: 10.1007/s12022-021-09666-1. Epub 2021 Mar 2.
4
Papillary Thyroid Cancer-Aggressive Variants and Impact on Management: A Narrative Review.甲状腺乳头状癌-侵袭性变异体及其对管理的影响:叙事性综述。
Adv Ther. 2020 Jul;37(7):3112-3128. doi: 10.1007/s12325-020-01391-1. Epub 2020 Jun 1.
5
Correlations between Molecular Landscape and Sonographic Image of Different Variants of Papillary Thyroid Carcinoma.甲状腺乳头状癌不同变体的分子特征与超声图像之间的相关性
J Clin Med. 2019 Nov 8;8(11):1916. doi: 10.3390/jcm8111916.
6
BRAF Mutations in an Italian Regional Population: Implications for the Therapy of Thyroid Cancer.意大利某地区人群中的BRAF突变:对甲状腺癌治疗的启示
Int J Endocrinol. 2015;2015:138734. doi: 10.1155/2015/138734. Epub 2015 Nov 26.
7
A 3-bp Deletion VK600-1E in the BRAF Gene Detected in a Young Woman with Papillary Thyroid Carcinoma.在一名年轻的甲状腺乳头状癌女性患者中检测到BRAF基因的3个碱基对缺失VK600-1E。
Endocr Pathol. 2015 Dec;26(4):309-14. doi: 10.1007/s12022-015-9387-2.
8
Clinical significance of V600E mutation in 154 patients with thyroid nodules.154例甲状腺结节患者中V600E突变的临床意义
Oncol Lett. 2015 Jun;9(6):2633-2638. doi: 10.3892/ol.2015.3119. Epub 2015 Apr 15.
9
Clinicopathological features of rare BRAF mutations in Korean thyroid cancer patients.韩国甲状腺癌患者中罕见BRAF突变的临床病理特征
J Korean Med Sci. 2014 Aug;29(8):1054-60. doi: 10.3346/jkms.2014.29.8.1054. Epub 2014 Jul 30.
10
Peptide nucleic acid clamp polymerase chain reaction reveals a deletion mutation of the gene in papillary thyroid carcinoma: A case report.肽核酸钳式聚合酶链反应揭示甲状腺乳头状癌中该基因的缺失突变:一例报告。
Exp Ther Med. 2013 Dec;6(6):1550-1552. doi: 10.3892/etm.2013.1332. Epub 2013 Oct 8.